Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phyllanthus emblica pharmaceutical composition and preparation method, preparation and anti-AIDS application thereof

The technology of a pharmaceutical preparation and emblica root can be used in drug combinations, pharmaceutical formulations, anti-tumor drugs and other directions, which can solve the problems of clinical effect against skin and mucous membrane lesions and unsatisfactory long-term intervention effect, and achieve stable effects, improve blood circulation, and supplement Camp blood effect

Inactive Publication Date: 2016-12-14
王捷
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there are few anti-AIDS traditional Chinese medicines and ethnic medicine compound preparations on the market, and the clinical effects, anti-skin and mucous membrane lesions and long-term intervention effects are not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phyllanthus emblica pharmaceutical composition and preparation method, preparation and anti-AIDS application thereof
  • Phyllanthus emblica pharmaceutical composition and preparation method, preparation and anti-AIDS application thereof
  • Phyllanthus emblica pharmaceutical composition and preparation method, preparation and anti-AIDS application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A pharmaceutical composition containing emblica, comprising an effective component a, the effective component a including the following raw materials in parts by weight: 10 parts of emblica, 1 part of medlar, 1 part of mulberry leaf, 1 part of lotus leaf, 1 part of chrysanthemum, 1 part of sealwort, 1 part of ginger and 1 part of licorice.

[0038] The present invention also provides a preparation method of a pharmaceutical composition containing emblica, which comprises the following steps in parts by weight:

[0039] Step 1. Pulverize the emblica in the above parts by weight, reflux extract twice with an ethanol solution with a volume fraction of 80%, and extract for 1 hour each time, and then filter to obtain the first filtrate and the first filter residue, and concentrate the first filtrate under reduced pressure Obtain the first thick paste that relative density is 1.2;

[0040] Step 2, decocting the first filter residue with water once, filtering, and concentrati...

Embodiment 2

[0044] A pharmaceutical composition containing emblica, comprising active component a, the effective component a comprising the following raw materials in parts by weight: 10 parts of emblica, 9 parts of medlar, 9 parts of mulberry leaves, 9 parts of lotus leaves, 9 parts of chrysanthemum, 9 parts of sealwort, 9 parts of ginger and 9 parts of licorice.

[0045] It also includes effective component b, which includes the following raw materials in parts by weight: 10 parts of emblica cotyledon, 9 parts of astragalus, 9 parts of scutellaria baicalensis, 9 parts of salvia miltiorrhiza, 9 parts of codonopsis pilosula, 9 parts of Ligustrum lucidum, golden 9 parts of Sakurako and 9 parts of Centella Asiatica.

[0046] The present invention also provides a preparation method of a pharmaceutical composition containing emblica, which comprises the following steps in parts by weight:

[0047] Step 1. Pulverize the above-mentioned emblica by weight, and reflux extraction with 95% ethanol...

Embodiment 3

[0055] A pharmaceutical composition containing emblica, comprising an effective component a, the effective component a including the following raw materials in parts by weight: 12 parts of emblica, 6 parts of medlar, 3 parts of mulberry leaves, 3 parts of lotus leaves, 3 parts of chrysanthemum, 2 parts of sealwort, 2 parts of ginger and 2 parts of licorice.

[0056] It also includes effective component b, which includes the following raw materials in parts by weight: 12 parts of Eucommia ulmoides leaves, 2 parts of Astragalus membranaceus, 4 parts of Scutellaria baicalensis, 2 parts of Salvia miltiorrhiza, 3 parts of Codonopsis pilosula, 3 parts of Ligustrum lucidum, golden cherry 3 parts, 3 parts of madder.

[0057] Mix the active components a and b in Example 3 at a ratio of 1:1, add an appropriate amount of flavoring agent, preservative, suspending agent or solubilizer, add water, shake well, and fill it to obtain an oral liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition containing phyllanthus emblica. The pharmaceutical composition comprises the effective component a, which comprises the following raw materials in parts by weight: 10 to 30 parts of phyllanthus emblica, 1 to 10 parts of medlar, 1 to 10 parts of folium mori, 1 to 10 parts of lotus leaf, 1 to 10 parts of chrysanthemum, 1 to 10 parts of rhizoma polygonatum, 1 to 10 parts of ginger and 1 to 10 parts of liquorice. The pharmaceutical composition has obvious antibacterial, anti-virus and anti-inflammatory effects, and improves the immunity of the body. In addition, the pharmaceutical composition has the functions of clearing away heat and detoxifying, nourishing yin and moistening dryness, replenishing qi and blood, replenishing kidney and spleen, and not only helping to restore the normal body temperature, and adjust the internal environment, and strengthen the body resistance to eliminate pathogenic factors, is a good medicine for the treatment of AIDS that has the remarkable effect and no adverse reactions and side effects, and is suitable for long-term intervention, and raw material resources are easily available.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine or ethnic medicine preparations. More specifically, the present invention relates to an anti-AIDS compound preparation of glucoside traditional Chinese medicine and national medicine. Background technique [0002] Amla emblica is the mature and dry fruit of Euphorbiaceae Phyllanthus emblica. Guangxi Zhuang Autonomous Region Zhuang Medicine Quality Standards (Volume 1, 2008 Edition) is recorded in Zhuang language Mangyin. "Tang Materia Medica" called it An Mo Le, Yu Gan, "Southern Vegetables and Trees" said "the leaves are thin, like a faint, the flowers are yellow, the food is like plums, blue and yellow, the core is round and six or seven ribs, the food is bitter first and then sweet. ", "Compendium of Materia Medica" is called Amo Luojia fruit, which contains "its taste is bitter and astringent at the beginning, and it becomes sweeter after a long time, so it is called emblica." Am...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P31/18A61P17/04A61P17/00A61P17/10A61P31/22A61P35/00A61P1/02
CPCA61K36/23A61K36/287A61K36/344A61K36/46A61K36/47A61K36/481A61K36/484A61K36/537A61K36/539A61K36/605A61K36/62A61K36/638A61K36/738A61K36/74A61K36/815A61K36/8969A61K36/9068A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2300/00
Inventor 王捷蒋伟哲叶勇李清黄增琼付书婕
Owner 王捷
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com